CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0328
+0.0028 (9.33%)
Jan 14, 2025, 3:31 PM EST
CV Sciences Revenue
CV Sciences had revenue of $3.87M in the quarter ending September 30, 2024, a decrease of -5.48%. This brings the company's revenue in the last twelve months to $15.62M, down -2.80% year-over-year. In the year 2023, CV Sciences had annual revenue of $16.00M, down -1.24%.
Revenue (ttm)
15.62M
Revenue Growth
-2.80%
P/S Ratio
0.32
Revenue / Employee
363.30K
Employees
43
Market Cap
5.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
Dec 31, 2020 | 24.43M | -29.27M | -54.50% |
Dec 31, 2019 | 53.70M | 5.45M | 11.30% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
Jun An Kang Group | 4.47M |
CV Sciences News
- 7 weeks ago - CV Sciences enters into agreement to acquire Extract Labs - Seeking Alpha
- 7 weeks ago - CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs - PRNewsWire
- 2 months ago - CV Sciences Q3: Revenue Stable Amid New Launches, Financing - Benzinga
- 2 months ago - CV Sciences, Inc. (CVSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CV Sciences Non-GAAP EPS of $0.00, revenue of $3.87M - Seeking Alpha
- 2 months ago - CV Sciences, Inc. Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024 - PRNewsWire
- 2 months ago - Marijuana Stock Movers For October 23, 2024 - Benzinga